ArticleCureus2026
Beyond Adenosine Deaminase (ADA) and Mycobacterial Growth Indicator Tube (MGIT): The Utility of Xpert MTB/RIF Ultra for Diagnosis and Resistance Determination in Suspected Tubercular Pleural Effusion in a High-Burden State.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiagnosis of tubercular pleural effusion (TPE) is difficult and always controversial unless proved microbiologically. Pleural fluid is almost always paucibacillary, leading to low microbiological yield. Physicians often rely on pleural fluid biochemistry and clinical judgment for initiating antitubercular therapy (ATT). Xpert
objectivesThis study aimed to evaluate the diagnostic utility of Xpert MTB/RIF Ultra in suspected TPE and assess its role in rifampicin resistance determination.
methodsThis retrospective observational study was conducted at a tertiary care center in Northern India. Patients with exudative lymphocytic pleural effusion, elevated adenosine deaminase levels, and clinic-radiological suspicion of TB who underwent pleural fluid Xpert MTB/ RIF Ultra and mycobacterial growth indicator tube (MGIT) culture testing were included. Clinical response to ATT and radiological improvement were assessed during follow-up.
resultsTwenty-one patients were included in the final analysis. Xpert MTB/RIF Ultra demonstrated positivity in 14 patients, while MGIT culture remained negative in all cases. All Ultra-positive patients showed significant clinical and radiological improvement following ATT, supporting the diagnosis of pleural TB despite MGIT culture negativity. Most of the Ultra-positive samples demonstrated "Trace" positivity with indeterminate rifampicin resistance results, limiting reliable drug resistance interpretation.
conclusionXpert MTB/RIF Ultra appears to be a useful adjunctive diagnostic tool in suspected TPE, where culture positivity is low. Although rifampicin resistance determination remains challenging in paucibacillary pleural fluid specimens, Ultra may help improve microbiological support for diagnosis alongside conventional clinical and biochemical assessment. Our findings correlate with the latest World Health Organization 2025 recommendations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.